Cargando…

Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51

BACKGROUND: Chagas Disease, a WHO- and NIH-designated neglected tropical disease, is endemic in Latin America and an emerging infection in North America and Europe as a result of population moves. Although a major cause of morbidity and mortality due to heart failure, as well as inflicting a heavy e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunatilleke, Shamila S., Calvet, Claudia M., Johnston, Jonathan B., Chen, Chiung-Kuang, Erenburg, Grigori, Gut, Jiri, Engel, Juan C., Ang, Kenny K. H., Mulvaney, Joseph, Chen, Steven, Arkin, Michelle R., McKerrow, James H., Podust, Larissa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409115/ https://www.ncbi.nlm.nih.gov/pubmed/22860142 http://dx.doi.org/10.1371/journal.pntd.0001736

Ejemplares similares

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
por: Chen, Chiung-Kuang, et al.
Publicado: (2009)

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010)

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
por: Vieira, Debora F., et al.
Publicado: (2014)

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
por: Calvet, Claudia M., et al.
Publicado: (2014)

Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
por: Engel, Juan C., et al.
Publicado: (1998)

4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection
por: Calvet, Claudia Magalhaes, et al.
Publicado: (2017)

CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
por: Debnath, Anjan, et al.
Publicado: (2017)

The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
por: Doyle, Patricia S., et al.
Publicado: (2011)

Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
por: Franco, Caio H., et al.
Publicado: (2020)

Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target
por: Choy, Jonathan W, et al.
Publicado: (2013)

Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole
por: Calvet, Claudia Magalhães, et al.
Publicado: (2020)

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
por: Chen, Yen Ting, et al.
Publicado: (2010)

Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2015)

Quantitative Structure–Activity Relationships for Structurally Diverse Chemotypes Having Anti-Trypanosoma cruzi Activity
por: de Souza, Anacleto S., et al.
Publicado: (2019)

Drug Strategies Targeting CYP51 in Neglected Tropical Diseases
por: Choi, Jun Yong, et al.
Publicado: (2014)

High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
por: Bernatchez, Jean A., et al.
Publicado: (2020)

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
por: Moraes, Carolina B., et al.
Publicado: (2014)

A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit
por: De Muylder, Geraldine, et al.
Publicado: (2011)

3-H-[1,2]Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies
por: Couto, Marcos, et al.
Publicado: (2015)

Identification of Leucinostatins from Ophiocordyceps sp. as Antiparasitic Agents against Trypanosoma cruzi
por: Bernatchez, Jean A., et al.
Publicado: (2022)

Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
por: Riley, Jennifer, et al.
Publicado: (2015)

Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
por: Dauchy, Frédéric-Antoine, et al.
Publicado: (2016)

Correction: Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
Publicado: (2017)

The recombinase Rad51 plays a key role in events of genetic exchange in Trypanosoma cruzi
por: Alves, Ceres Luciana, et al.
Publicado: (2018)

Tirandamycin biosynthesis is mediated by co-dependent oxidative enzymes
por: Carlson, Jacob C., et al.
Publicado: (2011)

Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction
por: Calvet, Claudia M., et al.
Publicado: (2012)

Mining a Cathepsin Inhibitor Library for New Antiparasitic Drug Leads
por: Ang, Kenny K. H., et al.
Publicado: (2011)

The in vivo and in vitro roles of Trypanosoma cruzi Rad51 in the repair of DNA double strand breaks and oxidative lesions
por: Gomes Passos Silva, Danielle, et al.
Publicado: (2018)

Profiling the Trypanosoma cruzi Phosphoproteome
por: Marchini, Fabricio K., et al.
Publicado: (2011)

Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014)

Endothelial Transmigration by Trypanosoma cruzi
por: Coates, Bria M., et al.
Publicado: (2013)

The N-myristoylome of Trypanosoma cruzi
por: Roberts, Adam J., et al.
Publicado: (2016)

Oral Transmission of Trypanosoma cruzi, Brazilian Amazon
por: Santana, Rosa Amélia G., et al.
Publicado: (2019)

A high throughput drug screen for Entamoeba histolytica identifies a new lead and target
por: Debnath, Anjan, et al.
Publicado: (2012)

Specific inhibition of the differentiation of Trypanosoma cruzi
Publicado: (1984)

OBSERVATIONS ON THE RESPIRATION OF TRYPANOSOMA CRUZI IN CULTURE
por: von Brand, Theodor, et al.
Publicado: (1946)

Autochthonous Transmission of Trypanosoma cruzi, Louisiana
por: Dorn, Patricia L., et al.
Publicado: (2007)

Flagellar Motility of Trypanosoma cruzi Epimastigotes
por: Ballesteros-Rodea, G., et al.
Publicado: (2012)

Trypanosoma cruzi–Host Cell Interaction
por: De Souza, Wanderley
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aboot36ehv2tj70se569u0qn2e